Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology
Blue Bell, PA – July 10, 2025 – Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud…